Transcriptome-Powered Pluripotent Stem Cell Differentiation for Regenerative Medicine

Pluripotent stem cells are endless sources for in vitro engineering human tissues for regenerative medicine. Extensive studies have demonstrated that transcription factors are the key to stem cell lineage commitment and differentiation efficacy. As the transcription factor profile varies depending o...

Full description

Bibliographic Details
Main Authors: Derek A. Ogi, Sha Jin
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/12/10/1442
_version_ 1797600626920652800
author Derek A. Ogi
Sha Jin
author_facet Derek A. Ogi
Sha Jin
author_sort Derek A. Ogi
collection DOAJ
description Pluripotent stem cells are endless sources for in vitro engineering human tissues for regenerative medicine. Extensive studies have demonstrated that transcription factors are the key to stem cell lineage commitment and differentiation efficacy. As the transcription factor profile varies depending on the cell type, global transcriptome analysis through RNA sequencing (RNAseq) has been a powerful tool for measuring and characterizing the success of stem cell differentiation. RNAseq has been utilized to comprehend how gene expression changes as cells differentiate and provide a guide to inducing cellular differentiation based on promoting the expression of specific genes. It has also been utilized to determine the specific cell type. This review highlights RNAseq techniques, tools for RNAseq data interpretation, RNAseq data analytic methods and their utilities, and transcriptomics-enabled human stem cell differentiation. In addition, the review outlines the potential benefits of the transcriptomics-aided discovery of intrinsic factors influencing stem cell lineage commitment, transcriptomics applied to disease physiology studies using patients’ induced pluripotent stem cell (iPSC)-derived cells for regenerative medicine, and the future outlook on the technology and its implementation.
first_indexed 2024-03-11T03:50:30Z
format Article
id doaj.art-37c140d95e00449aacdfa7c43ec7e0e5
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-11T03:50:30Z
publishDate 2023-05-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-37c140d95e00449aacdfa7c43ec7e0e52023-11-18T00:53:42ZengMDPI AGCells2073-44092023-05-011210144210.3390/cells12101442Transcriptome-Powered Pluripotent Stem Cell Differentiation for Regenerative MedicineDerek A. Ogi0Sha Jin1Department of Biomedical Engineering, Thomas J. Watson College of Engineering and Applied Sciences, State University of New York at Binghamton, Binghamton, NY 13902, USADepartment of Biomedical Engineering, Thomas J. Watson College of Engineering and Applied Sciences, State University of New York at Binghamton, Binghamton, NY 13902, USAPluripotent stem cells are endless sources for in vitro engineering human tissues for regenerative medicine. Extensive studies have demonstrated that transcription factors are the key to stem cell lineage commitment and differentiation efficacy. As the transcription factor profile varies depending on the cell type, global transcriptome analysis through RNA sequencing (RNAseq) has been a powerful tool for measuring and characterizing the success of stem cell differentiation. RNAseq has been utilized to comprehend how gene expression changes as cells differentiate and provide a guide to inducing cellular differentiation based on promoting the expression of specific genes. It has also been utilized to determine the specific cell type. This review highlights RNAseq techniques, tools for RNAseq data interpretation, RNAseq data analytic methods and their utilities, and transcriptomics-enabled human stem cell differentiation. In addition, the review outlines the potential benefits of the transcriptomics-aided discovery of intrinsic factors influencing stem cell lineage commitment, transcriptomics applied to disease physiology studies using patients’ induced pluripotent stem cell (iPSC)-derived cells for regenerative medicine, and the future outlook on the technology and its implementation.https://www.mdpi.com/2073-4409/12/10/1442transcriptomicshuman stem cell differentiationRNA sequencing and data analysisdifferential gene expression
spellingShingle Derek A. Ogi
Sha Jin
Transcriptome-Powered Pluripotent Stem Cell Differentiation for Regenerative Medicine
Cells
transcriptomics
human stem cell differentiation
RNA sequencing and data analysis
differential gene expression
title Transcriptome-Powered Pluripotent Stem Cell Differentiation for Regenerative Medicine
title_full Transcriptome-Powered Pluripotent Stem Cell Differentiation for Regenerative Medicine
title_fullStr Transcriptome-Powered Pluripotent Stem Cell Differentiation for Regenerative Medicine
title_full_unstemmed Transcriptome-Powered Pluripotent Stem Cell Differentiation for Regenerative Medicine
title_short Transcriptome-Powered Pluripotent Stem Cell Differentiation for Regenerative Medicine
title_sort transcriptome powered pluripotent stem cell differentiation for regenerative medicine
topic transcriptomics
human stem cell differentiation
RNA sequencing and data analysis
differential gene expression
url https://www.mdpi.com/2073-4409/12/10/1442
work_keys_str_mv AT derekaogi transcriptomepoweredpluripotentstemcelldifferentiationforregenerativemedicine
AT shajin transcriptomepoweredpluripotentstemcelldifferentiationforregenerativemedicine